Cover Image

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hakim‐Moulay Dehbi, Sean Devlins, Alexia Iasonos, Matthew Nankivell, Duncan Gilbert, John O'Quigley
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sample Size Calculation for the ROCI Design
by: Henry Bern, et al.
Published: (2026)

A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
by: Antonio Olivas‐Martinez, et al.
Published: (2026)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
by: Huiman Barnhart, et al.
Published: (2025)

Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs
by: Kunhai Qing, et al.
Published: (2025)

DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
by: Meizi Liu, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
by: Andrew Hall, et al.
Published: (2026)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
by: Yingjie Qiu, et al.
Published: (2026)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
by: Melody A. Owen, et al.
Published: (2025)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
by: Holger Dette, et al.
Published: (2025)

Nothing to See Here? A Non‐Inferiority Approach to Parallel Trends
by: Alyssa Bilinski, et al.
Published: (2026)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
by: Yichen Yan, et al.
Published: (2025)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
by: Rebecca B. Silva, et al.
Published: (2024)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
by: Elizabeth L. Turner, et al.
Published: (2026)

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
by: Chloe E. Falke, et al.
Published: (2025)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
by: Abdollah Safari, et al.
Published: (2026)

Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial
by: Fei Heng, et al.
Published: (2025)

Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models
by: Dipro Mondal, et al.
Published: (2025)

A Note on the Sample Size Formula for a Win Ratio Endpoint
by: Se Yoon Lee
Published: (2025)

A Variance Estimator for Marginal Cox Regression Models Fit to Non‐Nested Multilevel Data
by: Peter C. Austin
Published: (2025)

Comments on “Sample Size Adaptation Designs and Efficiency Comparison With Group Sequential Designs”
by: Meinhard Kieser, et al.
Published: (2025)

On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
by: David S. Robertson, et al.
Published: (2025)

BEAM: Bayesian Hybrid Design With Adaptive Sample Size Through Multisource Exchangeability Modeling
by: Feng Tian, et al.
Published: (2025)

COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
by: Kai Chen, et al.
Published: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
by: Masahiro Kojima, et al.
Published: (2026)

Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available
by: Marie Analiz April Limpoco, et al.
Published: (2024)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)

Improving the Effectiveness of Sample Size Re‐Estimation: An Operating Characteristic Focused, Hybrid Frequentist‐Bayesian Approach
by: Ping Gao
Published: (2025)

Bayesian Estimation of Hierarchical Linear Models From Incomplete Data: Cluster‐Level Interaction Effects and Small Sample Sizes
by: Dongho Shin, et al.
Published: (2025)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
by: Junichi Asano, et al.
Published: (2026)

Marginally Interpretable Spatial Logistic Regression With Bridge Processes
by: Changwoo J. Lee, et al.
Published: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)

Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies
by: Abderrahmane Bourredjem, et al.
Published: (2024)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
by: Guangyong Zou, et al.
Published: (2024)

Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model
by: Ping Xie, et al.
Published: (2024)

Estimating Risk Factors for Pathogenic Dose Accrual From Longitudinal Data
by: Daniel K. Sewell, et al.
Published: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)

Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis
by: Patrick van Hage, et al.
Published: (2025)